---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027053"
form_type: "8-K"
ticker: "MIRA"
cik: "0001904286"
company_name: "MIRA PHARMACEUTICALS, INC."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T05:00:26.177301+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# MIRA Pharmaceuticals closes $8.9M IPO; shares begin trading on Nasdaq

## Summary
- Priced 1,275,000 shares at $7.00; gross proceeds of $8.9M.
- Nasdaq Capital Market listing under 'MIRA'; trading began Aug 3, 2023.
- Underwriters granted 45-day over-allotment option for 191,250 shares.
- Issued representative's warrants for 63,750 shares at $7.00, exercisable for 5 years.
- Shares issued to MZ as compensation for IPO-related services remain unregistered.

## SEC filing metadata
- accession: 0001493152-23-027053
- form_type: 8-K
- ticker: MIRA
- cik: 0001904286
- company_name: MIRA PHARMACEUTICALS, INC.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/0001493152-23-027053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027053
- JSON: https://secwatch.observer/filing/0001493152-23-027053.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027053.txt

## Key facts
- Material Agreements
  MIRA PHARMACEUTICALS, INC. entered into Underwriting Agreement with Kingswood Investments, division of Kingswood Capital Partners, LLC (effective 2023-08-02).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Kingswood Investments, division of Kingswood Capital Partners, LLC
  - Effective: 2023-08-02
  source text: On August 2, 2023, MIRA Pharmaceuticals, Inc. (the “Company”) entered into an Underwriting Agreement with Kingswood Investments, division of Kingswood Capital Partners, LLC (“Kingswood”) on behalf of itself and as representative of the underwriters named therein (the “Underwriting Agreement”), pursuant to which the Company issued and sold, in an underwritten public offering (the “Public Offering”), 1,275,000 shares of common stock, $0.0001 par value per share (“Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/0001493152-23-027053-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.